Clinical Trials Logo

Fecal Impaction clinical trials

View clinical trials related to Fecal Impaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04148248 Recruiting - Constipation Clinical Trials

A Pilot Study to Explore the Role of Gut Flora in Chronic Constipation

Start date: March 2, 2020
Phase:
Study type: Observational

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding chronic constipation

NCT ID: NCT02575040 Recruiting - Ulcerative Colitis Clinical Trials

Efficacy of Fecal Microbiota Transplantation for Inflammatory Bowel Disease

Start date: May 2015
Phase: Phase 3
Study type: Interventional

The gut microbiota is determined to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body's metabolism. Evidence from animal and human studies strongly supports the link between intestinal bacteria flora and inflammatory bowel diseases. Lots of studies showed its efficacy in treatment of severe Clostridium difficile colitis. Corticosteroid dependence in patients with ulcerative colitis (UC) and Crohn's disease (CD) is an important clinical problem and maintenance of steroid-free remission is a key treatment goal. Early studies using fecal microbiota transplantation (FMT) for Ulcerative Colitis (UC) and Crohn's diseases have also met with success. This is an first step into investigating the potential efficacy of standardized FMT through terminal ileum for UC and CD, the investigators propose to determine the efficiency and safety of FMT in a series of 80 patients with moderate to severe UC and CD.